Innovative Egg Assessment Tool From Canadian Med-Tech Startup Future Fertility Has Been Adopted For Patient Use by Trio Fertility

August 11, 2020

TORONTO, Aug. 11, 2020 /PRNewswire/ – Canadian startup company Future Fertility has commercially launched a product that is providing a new solution in the field of Assisted Reproductive Technology (ART). Their newly marketed product Violet™ is a cloud-based software that assesses the probability of an oocyte (human egg) to successfully fertilize and reach a blastocyst embryo stage. Violet™, an AI-based image technology that has been optimized through scientific collaborations with several In-Vitro Fertilization (IVF) clinics around the world, analyzes 2-D images of a patient’s eggs in real-time. Until now, there has been no accepted method to visually grade an egg or predict its reproductive potential.

> Continue reading

Related posts

January 08, 2021

TRIO – Canada’s First Lab to Adopt Violet

Violet™ is a non-invasive, AI-based software tool that assesses and analyzes images of a patient’s eggs to predict the chances [...]
February 14, 2019

IVF coverage by employers on the rise? How to know what your company offers?

Infertility coverage is the in-demand benefit of the moment for women and more companies are stepping up to offer to [...]
February 19, 2019

Cruel twist of fate for single woman who froze her eggs in her 30s to ‘free her career’

MANHATTAN BEACH, Calif. — Brigitte Adams caused a sensation four years ago when she appeared on the cover of Bloomberg [...]